SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    RiesLE, EisnerMP, KosaryCL, et al., eds. SEER Cancer Statistics Review, 1975–2000. Bethesda, MD: National Cancer Institute; 2003.
  • 2
    McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998; 128: 729736.
  • 3
    Jacobellis J, Cutter G. Mammography screening and difference in stage of disease by race/ethnicity. Am J Public Health. 2002; 92: 11441150.
  • 4
    Jones BA, Kasl SV, Curnen MG, Owens PH, Dubrow R. Can mammography screening explain the racial difference in stage at diagnosis of breast cancer? Cancer. 1995; 75: 21032113.
  • 5
    Jones BA, Patterson EA, Calvocoressi L. Mammography screening in African American women: Evaluating the research. Cancer. 2003; 97 ( Suppl 1): 258272.
  • 6
    Bastani R, Yabroff KR, Myers RE, Glenn B. Interventions to improve follow-up of abnormal findings in cancer screening. Cancer. 2004; 101 ( Suppl 5): 11881200.
  • 7
    Jones BA, Dailey A, Calvocoressi L, Reams K, Kasl SV, Lee CH, Hsu H. Inadequate follow-up of abnormal screening mammogram: Findings from the race differences in screening mammography process study. Cancer Causes Control. 2005; 16: 809821.
  • 8
    Caplan LS, May DS, Richardson LC. Time to diagnosis and treatment of breast cancer: Results from the National Breast and Cervical Cancer Early Detection Program, 1991–1995. Am J Public Health. 2000; 90: 130134.
  • 9
    Chang SW, Kerlikowske K, Napoles-Springer A, Posner SF, Sickles EA, Perez-Stable EJ. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer. 1996; 78: 13951402.
  • 10
    Kerlikowske K. Timeliness of follow-up after abnormal screening mammography. Breast Cancer Res Treat. 1996; 40: 5364.
  • 11
    Webber PA, Fox P, Zhang X, Pond M. An examination of differential follow-up rates in breast cancer screening. J Community Health. 1996; 21: 123132.
  • 12
    Centers for Medicare and Medicaid Services. Evidence report and evidence-based recommendations: Cancer prevention and treatment demonstration for ethnic and racial minorities. Bethesda, MD: United States Department of Health and Human Services; 2003.
  • 13
    Dohan D, Schrag D. Using navigators to improve care of underserved patients. Cancer. 2005; 104: 848855.
  • 14
    Healthcare Association of New York State (HANYS). Breast health patient navigator resource kit; 2002. Available at www.hanys.org. Accessed August 15, 2005.
  • 15
    Capitman JA, Bhalotra S, Ruwe M. Cancer and Elders of Color: Opportunities for Reducing Health Disparities. Aldershot, Hampshire, England: Ashgate; 2005.
  • 16
    National Institutes of Health. Patient navigation research program; 2004. Available from http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-05-019.html. Accessed August 2005.
  • 17
    Avon Foundation Breast Cancer Crusade. Available at www.avoncompany.com/women/avoncrusade/2005_BC_funding_guidelines.pdf. Accessed August 28, 2005.
  • 18
    Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995; 3: 1930.
  • 19
    Longest BB, Young GJ. Coordination and Communication. In: ShortellSK, KaluznyAD, eds. Health Care Management: Organization Design and Behavior, 4th edn. Albany, NY: Delmar Publishers; 2000: 237275.
  • 20
    Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet. 1999; 353: 11191126.
  • 21
    SAS Institute. SAS release 8.02. Cary, NC: SAS Institute; 1999–2001.
  • 22
    Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002; 27: 299309.
  • 23
    Benard VB, Lee NC, Piper M, Richardson L. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991–1998 (United States). Cancer Causes Control. 2001; 12: 6168.
  • 24
    Bennetts A, Irwig L, Oldenburg B, et al. PEAPS-Q: A questionnaire to measure the psychosocial effects of having an abnormal pap smear. Psychosocial effects of abnormal Pap smears questionnaire. J Clin Epidemiol. 1995; 48: 12351243.
  • 25
    Brett J, Austoker J. Women who are recalled for further investigation for breast screening: Psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med. 2001; 23: 292300.
  • 26
    Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract. 1993; 37: 583587.
  • 27
    Crane LA. Social support and adherence behavior among women with abnormal Pap smears. J Cancer Educ. 1996; 11: 164173.
  • 28
    Deane KA, Degner LF. Information needs, uncertainty, and anxiety in women who had a breast biopsy with benign outcome. Cancer Nurs. 1998; 21: 117126.
  • 29
    Haas J, Kaplan C, McMillan A, Esserman LJ. Does timely assessment affect the anxiety associated with an abnormal mammogram result? J Womens Health Gend Based Med. 2001; 10: 599605.
  • 30
    Hunt LM, De Voogd KB, Soucy MD, Longworth JC. Exploring loss to follow-up: Abnormal Pap screening in Hispanic patients. Cancer Pract. 2002; 10: 122129.
  • 31
    Lauver D, Rubin M. Women's concerns about abnormal Papanicolaou test results. J Obstet Gynecol Neonatal Nurs. 1991; 20: 154159.
  • 32
    Lauver DR, Kruse K, Baggot A. Women's uncertainties, coping, and moods regarding abnormal Papanicolaou results. J Womens Health Gend Based Med. 1999; 8: 11031112.
  • 33
    McCarthy BD, Yood MU, Janz NK, Boohaker EA, Ward RE, Johnson CC. Evaluation of factors potentially associated with inadequate follow-up of mammographic abnormalities. Cancer. 1996; 77: 20702076.
  • 34
    McKee MD, Caban A, Burton W, Mulvihill M. Women's knowledge and experience of atypical Pap results in a high risk community. Women Health. 2002; 36: 1931.
  • 35
    Rojas M, Mandelblatt J, Cagney K, Kerner J, Freeman H. Barriers to follow-up of abnormal screening mammograms among low-income minority women.Cancer Control Center of Harlem. Ethn Health. 1996; 1: 221228.
  • 36
    Shinn E, Basen-Engquist K, Le T, et al. Distress after an abnormal Pap smear result: Scale development and psychometric validation. Prev Med. 2004; 39: 404412.
  • 37
    Zapka JG, Puleo E, Taplin SH, et al. Processes of care in cervical and breast cancer screening and follow-up the importance of communication. Prev Med. 2004; 39: 8190.
  • 38
    Institute of Medicine. Crossing the Quality Chiasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
  • 39
    Ward MD, Rieve JA. The role of case management in disease management. In: ToddWE, NashE, eds. Disease Management: A Systems Approach to Improving Patient Outcomes. Chicago, IL: American Hospital Publishing; 1997: 235259.
  • 40
    Norris SL, Nichols PJ, Caspersen CJ, et al., and the Task Force on Community Preventive Services. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002; 22 ( Suppl 4): 1538.
  • 41
    Centers for Medicare and Medicaid Services. Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities 2005. Available at www.cms.hhs.gov/researchers/demos/CPTD/FRN12_23_04.pdf.
  • 42
    United States Senate. House Committee Report. Patient Navigator Outreach and Chronic Disease Prevention Act of 2005, 109th Congress, 1st session, 2005.
  • 43
    United States Senate. House Committee Report. Patient Navigator Outreach and Chronic Disease Prevention Act of 2003, 108th Congress, 1st session, 2003.
  • 44
    Champion V, Maraj M, Hui S, Perkins AJ, Tierney W, Menon U, Skinner CS. Comparisons of tailored interventions to increase mammography screening in nonadherent older women. Prev Med. 2003: 36; 150158.
  • 45
    Olivotto IA, Borugian MJ, Kan L, et al. Improving the time to diagnosis after an abnormal screening mammogram. Can J Public Health. 2001; 92: 366371.
  • 46
    Manfredi C, Lacey L, Warnecke R. Results of an intervention to improve compliance with referrals for evaluation of suspected malignancies at neighborhood public health centers. Am J Public Health. 1990; 80: 8587.
  • 47
    Engelstad LP, Stewart SL, Nguyen BH, Bedeian KL, Rubin MM, Pasick RJ, Hiatt RA. Abnormal Pap smear follow-up in a high-risk population. Cancer Epi Bio Prev. 2001: 10; 10151020.
  • 48
    Ell K, Vourlekis B, Muderspach L, et al. Abnormal cervical screen follow-up among low income Latinas: Project safe. J Womens Health Gend Based Med. 2002; 11: 639651.